Leptin Promotes Invasiveness of Murine Renal Cancer Cells Via Extracellular Signal-Regulated Kinases and Rho Dependent Pathway

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1636-1641

  Horiguchi, Akio ^a   Sumitomo, Makoto ^a   Asakuma, Junichi ^a   Asano, Takako ^a   Zheng, Rong ^b   Asano, Tomohiko ^a   Nanus, David M ^b   Hayakawa, Masamichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Division of Solid Tumor Oncology   (United States)

Author keywords

kidney; kidney neoplasms; neoplasm invasiveness; obesity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; LEPTIN; LEPTIN RECEPTOR; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; LEPTIN; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM INVASIVENESS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RHO GTP-BINDING PROTEINS; RNA, MESSENGER;

EID: 33748260187     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.040     Document Type: Article

References (20)

1. Weigle D.S., Bukowski T.R., Foster D.C., Holderman S., Kramer J.M., Lasser G., et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96 (1995) 2065
2. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68 (2000) 437
3. Frank S., Stallmeyer B., Kampfer H., Kolb N., and Pfeilschifter J. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106 (2000) 501
4. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683
5. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., et al. Potential role of leptin in angiogenesis. leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33 (2001) 95
6. Ishikawa M., Kitayama J., and Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10 (2004) 4325
7. Rasmuson T., Grankvist K., Jacobsen J., Olsson T., and Ljungberg B. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43 (2004) 744
8. Hu X., Juneja S.C., Maihle N.J., and Cleary M.P. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94 (2002) 1704
9. Frankenberry K.A., Somasundar P., McFadden D.W., and Vona-Davis L.C. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 188 (2004) 560
10. Cauzac M., Czuba D., Girard J., and Hauguel-de Mouzon S. Transduction of leptin growth signals in placental cells is independent of JAK-STAT activation. Placenta 24 (2003) 378
11. Yu M.C., and Ross R.K. Obesity, hypertension, and renal cancer. N Engl J Med 344 (2001) 531
12. Goetze S., Bungenstock A., Czupalla C., Eilers F., Stawowy P., Kintscher U., et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 40 (2002) 748
13. Horiguchi A., Sumitomo M., Asakuma J., Asano T., and Hayakawa M. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis. Clin Cancer Res 10 (2004) 8648
14. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 14 (2000) 2329
15. Jo M., Thomas K.S., Somlyo A.V., Somlyo A.P., and Gonias S.L. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem 277 (2002) 12479
16. Takahashi Y., Okimura Y., Mizuno I., Takahashi T., Kaji H., Uchiyama T., et al. Leptin induces tyrosine phosphorylation of cellular proteins including STAT-1 in human renal adenocarcinoma cells, ACHN. Biochem Biophys Res Commun 228 (1996) 859
17. Oelmann E., Haghgu S., Kulimova E., Serve H., Schmitmann C., and Berdel W.E. Re. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 95 (2003) 1171
18. Brahmbhatt A.A., and Klemke R.L. ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis. J Biol Chem 278 (2003) 13016
19. Pawlak G., and Helfman D.M. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol Biol Cell 13 (2002) 336
20. Tourani J.M., Pfister C., Tubiana N., Ouldkaci M., Prevot G., Lucas V., et al., Subcutaneous Administration Propeukin Program Cooperative Group. Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma. final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design. J Clin Oncol 21 (2003) 3987